AAAAAA
Results: 1-25/38
Authors:
CUTULI B
PETIT T
HOFFSTETTER S
VELTEN M
DUFOUR P
GIRON C
LEDERLIN P
JUNG GM
BERGERAT JP
MALOISEL F
BEY P
OBERLING F
Citation: B. Cutuli et al., TREATMENT OF SUBDIAPHRAGMATIC HODGKINS-DISEASE - LONG-TERM RESULTS AND SIDE-EFFECTS, Oncology Reports, 5(6), 1998, pp. 1513-1518
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Bone marrow transplantation, 21, 1998, pp. 585-585
Authors:
MOUNIER N
MOREL P
HAIOUN C
COIFFIER B
TILLY H
CHATELAIN C
LEDERLIN P
THYSS A
HERBRECHT R
GISSELBRECHT C
LEPAGE E
Citation: N. Mounier et al., A MULTIVARIATE-ANALYSIS OF THE SURVIVAL OF PATIENTS WITH AGGRESSIVE LYMPHOMA - VARIATIONS IN THE PREDICTIVE VALUE OF PROGNOSTIC FACTORS DURING THE COURSE OF THE DISEASE, Cancer, 82(10), 1998, pp. 1952-1962
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH-RP-93/, British Journal of Haematology, 102(1), 1998, pp. 148-148
Authors:
MALOISEL F
BENBOUBKER L
CARCEL C
LEDERLIN P
SEDILLOT M
RAPP MJ
GARDEMBAS M
GANHDOUR C
BLANC M
CHRISTIAN B
CASTAIGNE S
CHERON N
CHAUVENET L
DREYFUSS B
SALLES B
MOREAU P
PEGOURIE B
OBERLING F
Citation: F. Maloisel et al., HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY, British Journal of Haematology, 102(1), 1998, pp. 191-191
Authors:
BASTION YB
BLAY JY
DIVINE M
BRICE P
BORDESSOULE D
SEBBAN C
BLANC M
TILLY T
LEDERLIN P
DECONINCK E
SALLES B
DUMONTET C
BRIERE J
COIFFIER B
Citation: Yb. Bastion et al., ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - DISEASE PRESENTATION, RESPONSE TO TREATMENT, AND SURVIVAL - A GROUPE DETUDE DES LYMPHOMES DE LADULTE STUDY ON 453 PATIENTS OLDER THAN 69 YEARS, Journal of clinical oncology, 15(8), 1997, pp. 2945-2953
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
BASTION Y
COIFFIER B
BRICE P
BOSLY A
DUPRIEZ B
NOUVEL C
TILLY H
LEDERLIN P
BIRON P
BRIERE J
GAULARD P
REYES F
Citation: C. Haioun et al., BENEFIT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION OVER SEQUENTIAL CHEMOTHERAPY IN POOR-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMA - UPDATED RESULTS OF THE PROSPECTIVE-STUDY LNH87-2, Journal of clinical oncology, 15(3), 1997, pp. 1131-1137
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
COIFFIER B
Citation: A. Bosly et al., LATE INTENSIFICATION IS SUPERIOR TO EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP93/, Experimental hematology, 25(8), 1997, pp. 16-16
Authors:
FEUGIER P
LAKOMSKY D
SERRURIER B
BALAT S
SCHUHMACHER A
HUMBERT JC
SCHOONEMAN F
LEDERLIN P
RACADOT E
JANOT C
Citation: P. Feugier et al., PERIPHERAL-BLOOD STEM-CELLS AND BONE-MARROW T-CELL DEPLETION BY COUNTERFLOW CENTRIFUGATION ELUTRIATION - COMPARATIVE-ANALYSIS, Experimental hematology, 25(8), 1997, pp. 297-297
Authors:
HULIN C
GUERCI A
DORVAUX V
RABY P
FEUGIER P
WITZ F
LEDERLIN P
Citation: C. Hulin et al., HEPATIC-ABSCESS DUE TO STREPTOCOCCUS-MILL ERI, La Revue de medecine interne, 18, 1997, pp. 340-341
Authors:
BACHEVALIER F
LEDERLIN P
LAUGROS A
DURR JF
LEQUANG D
Citation: F. Bachevalier et al., COLLAGENOUS COLITIS ASSOCIATED WITH A SYS TEMIC LUPUS-ERYTHEMATOSUS CIRCULATING ANTICOAGULANTS, La Revue de medecine interne, 18(11), 1997, pp. 908-909
Authors:
FERME C
BASTION Y
BRICE P
LEDERLIN P
DIVINE M
GABARRE J
ASSOULINE D
FERRANT A
BERGER F
LEPAGE E
Citation: C. Ferme et al., PROGNOSIS OF PATIENTS WITH ADVANCED HODGKINS-DISEASE - EVALUATION OF 4 PROGNOSTIC MODELS USING 344 PATIENTS INCLUDED IN THE GROUP-DETUDES-DES-LYMPHOMES-DE-LADULTE STUDY, Cancer, 80(6), 1997, pp. 1124-1133
Authors:
MARTEL V
GUERCI A
HUMBERT JC
GREGOIRE MT
CHERY M
LEDERLIN P
JONVEAUX P
Citation: V. Martel et al., DE-NOVO METHYLATION OF TUMOR-SUPPRESSOR GENES CDKN2A AND CDKN2B IS A RARE FINDING IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 99(2), 1997, pp. 320-324
Authors:
TILLY H
GAULARD P
LEPAGE E
DUMONTET C
DIEBOLD J
PLANTIER I
BERGER F
SYMANN M
PETRELLA T
LEDERLIN P
BRIERE J
Citation: H. Tilly et al., PRIMARY ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL PRESENTATION, IMMUNOPHENOTYPE, AND OUTCOME, Blood, 90(9), 1997, pp. 3727-3734
Authors:
HAIOUN C
LEPAGE E
SALLES G
MOREL P
GABARRE J
LEDERLIN P
TILLY H
BOSLY A
GAULARD P
COIFFIER B
GISSELBRECHT C
REYES F
Citation: C. Haioun et al., BONE-MARROW INVOLVEMENT AND LOW SERUM-ALBUMIN LEVEL ARE USEFUL TO BETTER PREDICT SURVIVAL OF POOR-RISK PATIENTS WITH AGGRESSIVE LYMPHOMA ASDEFINED BY THE AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX (AA-IPI), Blood, 90(10), 1997, pp. 3899-3899
Authors:
REMAN O
BROUSSE N
SOLALCELIGNY P
MORELLO R
LEDERLIN P
CHRISTIAN D
MOREL P
BLANC M
PICO J
BOULAT O
CONROY T
GISSELBRECHT C
HAIOUN C
MARTIN D
TURLURE P
SIMON M
DABOUT D
LEPORRIER M
Citation: O. Reman et al., 2-CHLORODEOXYADENOSINE (2CDA) IN RELAPSING OR REFRACTORY FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 1531-1531
Authors:
MOREL P
MUNCK JN
COIFFIER B
GISSELBRECHT C
LEDERLIN P
LAVAUD A
BOSLY A
TILLY H
QUESNEL B
THYSS A
SCHLAIFER D
BRIERE J
REYES F
Citation: P. Morel et al., ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS, Blood, 90(10), 1997, pp. 2610-2610
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Blood, 90(10), 1997, pp. 2639-2639
Authors:
REYES F
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
GISSELBRECHT C
Citation: F. Reyes et al., FAILURE OF FIRST-LINE INDUCTIVE HIGH-DOSE CHEMOTHERAPY (HDC) IN POOR-RISK PATIENTS (PTS) WITH AGGRESSIVE LYMPHOMA - UPDATED RESULTS OF THE RANDOMIZED LNH93-3 STUDY, Blood, 90(10), 1997, pp. 2640-2640
Authors:
GUERCI A
LEDERLIN P
REYES F
BORDESSOULE D
SEBBAN C
TILLY H
KERNEIS Y
BIRON P
GISSELBRECHT C
HERBRECHT R
COIFFIER B
Citation: A. Guerci et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ADMINISTRATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH A PIRARUBICIN-COMBINATION CHEMOTHERAPY REGIMEN, Annals of oncology, 7(9), 1996, pp. 966-969
Authors:
DIVINE M
LEPAGE E
BRIERE J
PAUTIER P
DUPRIEZ B
LEDERLIN P
MINEUR P
TILLY H
BLANC M
AUDHUY B
HERBRECHT R
COIFFIER B
REYES F
Citation: M. Divine et al., IS THE SMALL NON-CLEAVED-CELL LYMPHOMA HISTOLOGIC SUBTYPE A POOR PROGNOSTIC FACTOR IN ADULT PATIENTS - A CASE-CONTROLLED ANALYSIS, Journal of clinical oncology, 14(1), 1996, pp. 240-248
Authors:
GUERCI AP
MERLEMELET M
MORY F
BLUM A
FLOQUET J
DENEUVILLE M
BOISSEL P
LEDERLIN P
Citation: Ap. Guerci et al., ACTINOMYCOSIS AN NON-HODGKINS-LYMPHOMA, F ORTUITOUS ASSOCIATION, La Revue de medecine interne, 17(7), 1996, pp. 571-575
Authors:
PAITEL JF
GUERCI A
LEDERLIN P
Citation: Jf. Paitel et al., HAIRY-CELL LEUKEMIA - THERAPEUTIC APPROAC HES, La Revue de medecine interne, 17(5), 1996, pp. 399-406
Authors:
FEUGIER P
GUERCI A
NAFISSI S
LEDERLIN P
Citation: P. Feugier et al., ADULT UNIFOCAL AND MULTIFOCAL EOSINOPHILI C GRANULOMA - DIAGNOSTIC AND THERAPEUTIC APPROACHES - A REPORT OF 3 CASES, La Revue de medecine interne, 17(11), 1996, pp. 924-928
Authors:
GISSELBRECHT C
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
REVES F
Citation: C. Gisselbrecht et al., INTENSIFIED INDUCTION-PHASE INCLUDING AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION DOES NOT IMPROVE RESPONSE RATE AND SURVIVAL IN LYMPHOMA WITH AT LEAST 2 ADVERSE PROGNOSTIC FACTORS WHEN COMPARED TO ACVB REGIMEN, Blood, 88(10), 1996, pp. 470-470